Your browser doesn't support javascript.
loading
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2.
Fernandez, A P; Dauden, E; Gerdes, S; Lebwohl, M G; Menter, M A; Leonardi, C L; Gooderham, M; Gebauer, K; Tada, Y; Lacour, J P; Bianchi, L; Egeberg, A; Pau-Charles, I; Mendelsohn, A M; Rozzo, S J; Mehta, N N.
Afiliação
  • Fernandez AP; Departments of Dermatology and Pathology, Cleveland Clinic, Cleveland, OH, USA.
  • Dauden E; Dermatology Department, Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain.
  • Gerdes S; Department of Dermatology, Psoriasis-Center, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Lebwohl MG; Department of Dermatology, Mount Sinai Hospital, New York, NY, USA.
  • Menter MA; Division of Dermatology, Baylor Scott & White, and Texas A&M College of Medicine, Dallas, TX, USA.
  • Leonardi CL; Central Dermatology and Saint Louis University School of Medicine, St. Louis, MO, USA.
  • Gooderham M; Probity Medical Research, Peterborough, ON, Canada.
  • Gebauer K; SKiN Centre for Dermatology, Peterborough, ON, Canada.
  • Tada Y; Queen's University, Kingston, ON, Canada.
  • Lacour JP; Fremantle Dermatology, Fremantle, WA, Australia.
  • Bianchi L; Teikyo University, Tokyo, Japan.
  • Egeberg A; Department of Dermatology, University of Nice Sophia Antipolis, Nice, France.
  • Pau-Charles I; Dermatology Unit, Tor Vergata University Hospital, Rome, Italy.
  • Mendelsohn AM; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Rozzo SJ; Almirall R&D, Barcelona, Spain.
  • Mehta NN; Sun Pharmaceutical Industries, Inc., Princeton, NJ, USA.
J Eur Acad Dermatol Venereol ; 36(10): 1774-1783, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35460287
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Síndrome Metabólica / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Síndrome Metabólica / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Ano de publicação: 2022 Tipo de documento: Article